Skip to main content
. 2017 Jun 9;8(58):97890–97899. doi: 10.18632/oncotarget.18426

Table 2. Disease control rates of the two arms.

Event Rates Arm A: mFOLFIRI (n = 54) Arm B: mFOLFOX7 (n = 74)
No. % No. %
Disease control rate 32 59.3 49 66.3
Complete response 1 1.9 2 2.7
Partial response 5 9.3 5 6.8
Stable disease 26 48.1 42 56.8
Progression disease 17 31.5 18 24.3
Not assessable 5 9.3 7 9.5

Abbreviations: mFOLFIRI: folinic acid, fluorouracil, and irinotecan; mFOLFOX7: folinic acid, fluorouracil, and oxaliplatin.*p = 0.021.